Navigation Links
Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference
Date:12/5/2007

WESTMINSTER, Colo., Dec. 5 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that Paul L. Berns, President and CEO, will participate on the "Better Drugs & Novel Approaches To Cancer Therapy" panel at the 2007 RBC Capital Markets Healthcare Conference in New York.

The panel presentation will take place at 1:30 p.m. (Eastern) on December 13, 2007. There will be a live webcast of the presentation, which will be accessible through a link posted on the Allos website home page and investor relations section. The webcast will be available for replay on Allos' website through December 28, 2007.

About Allos Therapeutics, Inc.

Allos Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer. The Company's lead product candidate, PDX (pralatrexate), is a novel antifolate currently under evaluation in a pivotal Phase 2 (PROPEL) trial in patients with relapsed or refractory peripheral T-cell lymphoma. The PROPEL trial is being conducted under an agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating PDX in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeutic agent currently being evaluated in a Phase 1 trial in patients with advanced solid tumors or non-Hodgkins Lymphoma (NHL). For additional information, please visit the Company's website at

SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
2. Allos Therapeutics Reports Third Quarter 2007 Financial Results
3. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
4. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
5. Prime Therapeutics Receives TIPPS Certification
6. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
7. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
8. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
9. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
10. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
11. Prime Therapeutics Announces URAC Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) ... , The acquisition includes all of IBAM NA’s cyclotron sites and research and ... a robust regionally located business, as well as a large manufacturing hub in Noblesville, ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... Programs, with accountability for overall performance of the company’s Medicare and Federal Employee ... of Cambia’s strategy to deliver better health for members. In this role, Scott ...
(Date:8/3/2015)... ... 03, 2015 , ... Did you know that there are thousands of ... affordable home care options which A-1 Home Care Agency specialize in? In fact, diversity, ... A-1 Home Care Agency is known for. , With all ...
(Date:8/2/2015)... ... ... many “would be” entrepreneurs, starting a new business can prove to be daunting from ... business.” Neither needs be a major obstacle. , The U.S. has always been the ... be successful. The risks of starting a business can be high but the rewards can ...
(Date:8/1/2015)... ... August 02, 2015 , ... Back packs can be dangerous? Whaaat?! , ... packs can wreck havoc on a kid's spine. With school starting again, most kids ... school. Make sure you are aware of how to help them prevent injuries by ...
Breaking Medicine News(10 mins):Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2
... , MONDAY, June 6 (HealthDay News) -- A ... impairment -- sometimes a precursor to Alzheimer,s disease -- ... than those without cognitive problems. Mild cognitive ... as conditions that significantly disrupt daily life. It can, ...
... Migraine specialists attending the American Headache Society (AHS) science meeting ... for migraine research holds the most promise for winning the ... areas of research need, 40 % say an increase in ... of the disease -- more than early intervention in a ...
... nearly 68,000 deaths potentially could be prevented each year ... medications and cardiac devices, for all eligible heart failure ... major cause of death, morbidity and health care expenditures ... proven treatments that reduce mortality and improve quality of ...
... still needs improvement. In the current issue of Deutsches ... interdisciplinary S3 guideline entitled "Bariatric Surgery" ( Dtsch Arztebl Int ... Germany is overweight, and every fifth one is obese. Conservative ... to bring about a 10% to 20% loss of weight ...
... cells do not grow equally well everywhere in the ... they can grow. Many years ago researchers discovered that ... of nutrients by secreting specific factors. Now the immunologist ... the Max Delbrck Center for Molecular Medicine, MDC, Berlin-Buch ...
... Hall Institute have discovered a key molecule needed to kill ... from the institute,s Molecular Genetics of Cancer and Cancer and ... blood vessels to work the death- inducing molecule Bim is ... are based on a two- or three-pronged attack on both ...
Cached Medicine News:Health News:Forgetfulness About Paperwork, Medicines Might Herald Cognitive Decline 2Health News:Tens of thousands of lives could potentially be saved by key heart failure therapies 2Health News:Tens of thousands of lives could potentially be saved by key heart failure therapies 3Health News:Survival niche for cancer cells 2Health News:New strategy to attack tumor-feeding blood vessels 2
(Date:7/31/2015)... 31, 2015 Quietly, sedately, Morocco,s ... the domestic pharmaceutical industry is strong, with a well-developed ... high international standards. One place where the ... sub-Saharan Africa: Morocco has quietly become the second largest ... Africa . Indeed, Moroccan pharma companies have been ...
(Date:7/31/2015)... July 31, 2015  Semler Scientific, Inc. (Nasdaq: ... services to healthcare insurers and physician groups, today reported ... 2015. "In the second quarter of ... revenue growth of 54%, quarter over quarter revenue growth ... installed base of FloChec® units of 18%," said Doug ...
(Date:7/31/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, today ... to its board of directors. "Yujiro,s ... a tremendous asset to our board," said Bassil ... Xencor. "Xencor faces a range of opportunities for our ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... 2011 Yesterday American Regent, Inc. issued a letter ... of the letter follows: Dear Healthcare Professional, ... Injection, USP, 5mL Single Dose Vial, Lot# 0048, because ... visible particles that have been identified as glass delamination. ...
... Technology Catalysts International, leading global consultants to the ... identified probiotics as key to the future of ... only in digestive health, but also for promoting ...  New delivery and carrier technologies for probiotics increase ...
Cached Medicine Technology:Important Drug Information Notice Regarding Potassium Phosphates Injection, USP, 3 mM/mL Phosphorous; 4. 4 mEq/mL Potassium: 5 mL, 15 mL and 50 mL Single Dose Vials 2Important Drug Information Notice Regarding Potassium Phosphates Injection, USP, 3 mM/mL Phosphorous; 4. 4 mEq/mL Potassium: 5 mL, 15 mL and 50 mL Single Dose Vials 3Alternative Probiotic Applications Offer $2 Billion+ Market Potential 2Alternative Probiotic Applications Offer $2 Billion+ Market Potential 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: